Background The pandemic caused by severe acute respiratory coronavirus 2 (SARS-CoV-2) has had great effects on health systems worldwide, not only in relation to coronavirus disease 2019 (COVID-19) cases but also affecting patients with other pathologies. Methods ECIEN-2020 is an observational study conducted in a tertiary referral hospital in Navarra, Spain. It describes the effects of COVID-19 pandemic and the preventive measures adopted, in pediatric admissions for non-COVID-19 diseases. Admissions during March-June 2020 (first wave of the COVID-19 pandemic in Spain) are described and compared with the same quarter in 2019. A sub-analysis was performed delving into epidemiology. Patient characteristics (age, sex, past medical history), disease characteristics (symptoms, duration of symptoms, previous consultation in Primary Care Health Center), and admission characteristics (place and average stay) were analyzed. Results A 33% reduction in the number of pediatric hospital admissions was observed, decreasing from 529 hospitalizations in 2019 to 353 in 2020 (P < 0.001). This highlights a 48% reduction in patients admitted for pulmonary diseases. There were no significant changes in average hospital-stay, percentage of intensive care unit admissions, or in admissions for other reasons. Percentage of patients admitted among those seen in the emergency department rose from 5.1% in 2019 to 10.9% in 2020, whereas the total number of consultations in the emergency department decreased by 68%. Conclusion The pandemic and the measures adopted due to SARS-CoV-2 have significantly decreased pediatric admissions for non-COVID-19 diseases, especially due to a reduction in the hospitalization for respiratory diseases.
COVID-19 clinical manifestations and radiological findings are milder and less specific in children.• The presence of fever, and fever duration are clinical findings associated with pathological chest imaging.• The most common pattern seen in pathological chest X ray were bilateral diffuse interstitial pattern followed by perihilar bronchial wall thickening.• Consensual specific age-adjusted protocols regarding chest imaging indications in pediatric COVID-19, as the one developed, are needed.• Imaging should not be used as a screening tool or a routine complementary test in pediatric hospitalized patients with COVID-19.
Introduction: The pandemic caused by SARS-CoV-2 coronavirus has had great effects on health systems worldwide, not only in relation to COVID-19 cases, but also affecting patients with other pathologies.Material and methods: ECIEN-2020 is an observational study conducted in a tertiary referral hospital in Navarra, Spain to describe the effect of COVID-19 in pediatric admissions for NON-COVID diseases. Admissions during March-June 2020 (first wave of the COVID-19 pandemic in Spain) are described and compared with the same period in 2019. A sub-analysis was performed delving into epidemiology. Patient characteristics (age, sex, medical history), disease characteristics (symptoms, duration of symptoms, previous consultation in Primary Care Health Center) and admission characteristics (place and average stay) were analyzed.Results: A 33% reduction in the number of admissions was observed, decreasing from 529 in 2019 to 353 in 2020, highlighting a 48% reduction in patients admitted for pulmonary diseases. There were no significant changes in age, average stay, admissions for other reasons, or Intensive Care Unit admissions. Percentage of patients admitted among those seen in the emergency department rose from 5.1% in 2019 to 10.9% in 2020, whereas the total number of consultations in the emergency department decreased a 68%.Conclusions: The pandemic and the measures adopted due to SARS-CoV-2 have significantly decreased pediatric admissions for NON-COVID diseases, especially due to a reduction in hospitalization for respiratory diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.